Skip to content

Minimising young children’s anxiety through schools

Minimising Young Children’s Anxiety Through Schools (MY-CATS): a cluster randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN82398107
Enrollment
876
Registered
2021-01-14
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety disorders Mental and Behavioural Disorders Anxiety disorder, unspecified

Interventions

Schools will be randomised to the intervention or usual school practice arm in a 1:1 ratio stratified according to school-demographic information. An independent statistician will conduct randomisatio

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Schools: mainstream infant/primary school in England, with a minimum of two classes per target year. 2. Screening: child in Reception, Year 1 or Year 2 in a participating school (aged 4-7 years). One parent/carer will complete screening questionnaires for each child. 3. Trial: child screens positive on child anxiety symptoms, and/or behavioural inhibition, and/or parent/carer anxiety symptoms. 4. Qualitative interviews: parents/carers who take part in screening, school staff in participating schools and children of parents/carers who take part in the intervention

Exclusion criteria

Exclusion criteria: 1. Parent/carer does not have sufficient use of English to provide consent, complete measures and/or take part in the intervention 2. Parent/carer does not have frequent access to the internet, either at home or elsewhere

Design outcomes

Primary

MeasureTime frame
Absence/presence of an anxiety disorder measured using Anxiety Disorder Interview Schedule-Child Version-Parent Interview (ADIS-P) at 12-months post-randomisation

Secondary

MeasureTime frame
Current secondary outcome measures as of 21/12/2022: 1. Secondary clinical outcomes measured at baseline, 12 weeks and 12 months post-randomisation: 1.1. Child anxiety symptoms measured using the Preschool Anxiety Scale -parent/carer report 1.2. Inference caused by child anxiety measured using the Child Anxiety Life Interference Scale-Preschool version-parent/carer report 1.3. Child externalising symptoms measured using the Strengths and Difficulties Questionnaire-Externalising Scale-parent/carer report 2. Moderators of primary outcome measured at screening and baseline: 2.1. Child age, child gender, child ethnicity, parent gender, parent ethnicity, and family socioeconomic status measured using parent/carer-report bespoke socio-demographic questionnaire 2.2. Risk factors (child anxiety symptoms, behavioural inhibition, parent anxiety symptoms) and number/combination of risk factors measured using Preschool Anxiety Scale-parent/carer report, Approach subscale of the Short Temperament Scale for Children-parent/carer report, Generalised Anxiety Disorder-7 (GAD-7) Scale-parent self-report 3. Mediators of primary outcome measured at baseline, 12 weeks and 12 months post-randomisation: 3.1. Risk factors (child anxiety symptoms, behavioural inhibition, parent anxiety symptoms) measured using the Preschool Anxiety Scale-parent/carer report, Approach subscale of the Short Temperament Scale for Children-parent/carer report, Generalised Anxiety Disorder-7 (GAD-7) Scale 3.2. Additional intervention targets, including: 3.2.1. Parent overprotection measured using the Parental Overprotection Scale-parent/carer report 3.2.2. Parenting self-efficacy measured using the Parenting Sense of Competence Scale-self-efficacy subscale-parent/carer report 3.2.3. Child behavioural avoidance measured using the Child Avoidance Measure-parent/carer report 3.2.4. Child coping efficacy measured using an adapted version of the Coping Questionnaire-parent/carer report 3.2.5. Child intolerance of un

Countries

England, United Kingdom

Contacts

Public ContactTessa Reardon
tessa.reardon@psy.ox.ac.uk+44 (0)1865 271444

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026